ImmunoGen, Inc. ROE 2010-2023 | IMGN

Current and historical return on equity (ROE) values for ImmunoGen, Inc. (IMGN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-09-30 $-0.07B $0.56B -21.94%
2023-06-30 $-0.18B $0.49B -76.87%
2023-03-31 $-0.24B $0.12B -135.98%
2022-12-31 $-0.22B $0.16B -100.22%
2022-09-30 $-0.20B $0.18B -75.85%
2022-06-30 $-0.16B $0.25B -66.74%
2022-03-31 $-0.13B $0.31B -66.41%
2021-12-31 $-0.14B $0.33B -98.41%
2021-09-30 $-0.07B $0.08B -86.32%
2021-06-30 $-0.06B $0.07B -107.18%
2021-03-31 $-0.05B $0.09B -168.97%
2020-12-31 $-0.04B $0.09B -977.78%
2020-09-30 $-0.07B $-0.04B 189.19%
2020-06-30 $-0.07B $-0.03B 146.60%
2020-03-31 $-0.09B $-0.00B 152.14%
2019-12-31 $-0.10B $-0.08B 161.24%
2019-09-30 $-0.15B $-0.09B 353.22%
2019-06-30 $-0.18B $-0.07B 1852.63%
2019-03-31 $-0.18B $-0.03B -588.24%
2018-12-31 $-0.17B $0.01B -612.61%
2018-09-30 $-0.14B $0.05B -687.80%
2018-06-30 $-0.15B $0.09B 794.74%
2018-03-31 $-0.12B $-0.04B 139.64%
2017-12-31 $-0.10B $-0.02B 81.70%
2017-06-30 $-0.07B $-0.17B 46.03%
2017-03-31 $-0.11B $-0.17B 82.13%
2016-09-30 $-0.16B $-0.12B 237.26%
2016-06-30 $-0.15B $-0.08B 453.13%
2015-12-31 $-0.09B $-0.02B -395.56%
2015-09-30 $-0.04B $0.01B -91.30%
2014-12-31 $-0.05B $0.08B -58.06%
2014-09-30 $-0.06B $0.06B -60.61%
2013-12-31 $-0.01B $0.13B -6.27%
2013-09-30 $-0.04B $0.12B -27.91%
2012-12-31 $-0.07B $0.14B -56.90%
2012-09-30 $-0.06B $0.16B -49.89%
2011-12-31 $-0.05B $0.12B -42.34%
2011-09-30 $-0.05B $0.12B -47.17%
2010-12-31 $-0.04B $0.08B -50.81%
2010-09-30 $-0.04B $0.09B -55.27%
2009-12-31 $-0.03B $0.05B -57.97%